Biomedical Optics News and Analysis

  • Researchers achieve ultra fast 2D, time-resolved visualization of nanoscale biomedical events
    July 3, 2008 -- Researchers at the University of Michigan report unprecedented performance using a dual-camera setup to visualize nanoscale biomedical events. Their simultaneous framing and streak camera setup included a SIM8-02 Ultra Fast Framing Camera (Specialised Imaging Ltd) and an Optoscope SC-10 Streak Camera (Optronis Gmbh) in a single package....
  • Laser-activated antimicrobial breaks through drug resistance
    July 2, 2008 -- Researchers at the University College London have shown that a laser-activated antimicrobial can enable new treatments of bacterial infections, even those that are resistant to drugs. They used indocyanine green dye, which produces bacteria-killing chemicals when lit by a specific kind of laser light. This form of treatment is unlikely to produce resistance, the researchers say....
  • OptiMedica's new PASCAL Photocoagulator targets office-based ophthalmology practices
    July 1, 2008 -- OptiMedica Corp. (Santa Clara, Calif.), a global ophthalmic company, is debuting its new PASCAL Slim Line Photocoagulator this week at the World Ophthalmology Congress (Hong Kong, June 28 - July 2). Designed for office-based ophthalmology practices, the unit enables PASCAL pattern scanning -- an advancement from single-spot green laser photocoagulation -- in a compact design....
  • MDS Analytical acquires Blueshift Biotechnologies to strengthen cellular analysis offerings
    June 30, 2008 -- MDS Analytical Technologies (Sunnyvale, CA), says it has acquired Blueshift Biotechnologies (Sunnyvale, CA), maker of the the IsoCyte benchtop laser scanning cytometer and developer of screening platforms for life sciences research. The acquisition expands MDS's capabilities in cellular analysis....
  • FDA approves Metvixia and Aktilite CL128 for photodynamic therapy of AK
    June 27, 2008 -- Photocure ASA (Oslo, Norway) said today that the U.S. Food and Drug Administration (FDA) has approved its Metvixia cream, in combination with its Aktilite CL128 LED-based narrow band (630 nm) red light technology device, for the treatment of actinic keratosis (AK), a pre-cancerous skin lesion....
  • "Smart light engines" available to bioanalytical instrument manufacturers, researchers for Beta testing
    June 27, 2008 -- Lumencor (Beaverton, OR), a biotechnology company developing lighting solutions for the life sciences, says that its new generation of lighting for biotech is available for Beta testing at select labs in the US and Europe. The "smart light engines,' designed to replace traditional sources, target manufacturers of bioanalytical instruments and scientists involved in advanced research and diagnostic testing....
  • Sanochemia wins US patent for photodynamic bladder cancer diagnostic
    June 26, 2008 -- Sanochemia Pharmazeutika AG, (Vienna, Austria) has been granted a US patent for the manufacture of PVP hypericin formulations and their use in the diagnosis and treatment of bladder cancer. PVP hypericin is a fluorescent pigment that selectively accumulates in tumor cells and makes them easily visible when exposed to blue light. It promises to enable tumor detection easier, earlier and more reliably, and to have minimal side effects....
  • Geisinger uses optical molecular imaging for brain cancer research
    June 25, 2008 -- Geisinger Health System's Neuroscience Institute is using fluorescent nanospheres and an in-vivo multispectral imaging system to visualize brain tumors and lesions during treatment procedures. The goal is to make surgery for brain tumors and inflammatory lesions simpler and more precise....
  • NIH requests input on non-invasive brain imaging techniques
    June 24, 2008 -- The NIH Blueprint seeks input on new approaches to non-invasive imaging of brain structure and function -- particularly molecular imaging and neural connectivity imaging -- by August 1....
  • Award-winning system fights treatment-resistant cancer cells
    June 23, 2008 -- The Society of Nuclear Medicine gave its Molecular Imaging Center of Excellence (MICoE) Abstract Award to a group of researchers led by June-key Chung, a professor of nuclear medicine at Seoul National University College of Medicine in South Korea. The team developed a gene radiotherapy system that detects and treats cancer cells that are resistant to traditional chemotherapy and radiation. The system involves tracking a flourescent reporter gene with optical imaging....
+ More Biomedical Optics News and Analysis > 1 | 2 | 3 | 4 | 5 | 6

ad